Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIVEP2 divergent transcript (HIVEP2-DT), also known as PILA or PRMT1-interacting lncRNA, is a long non-coding RNA gene located on human chromosome 6. It is recognized by gene databases (e.g., Ensembl: ENSG00000232618, HGNC:55724) and shares genomic proximity with the HIVEP2 protein-coding locus but does not encode a protein. Unlike HIVEP2, which functions as a zinc finger transcription factor and is implicated in intellectual disability, HIVEP2-DT has not been documented as a direct molecular or therapeutic target, nor does it have established roles in diseases or as a biomarker. Its functional annotation is minimal, and its only suggested role, based on its alias, is potential interaction with PRMT1, but details are lacking in public resources as of mid-2025. Key distinctions: - HIVEP2-DT is an lncRNA, not a protein, receptor, enzyme, transporter, or canonical drug target. - Scarce scientific literature describes its function or any clinical relevance; it is distinct from the protein-coding HIVEP2 gene, which has established disease links. If you seek information on the protein-coding HIVEP2 (HIVEP zinc finger 2; synonym: Schnurri-2), see those entries for disease associations and biological functions.
None identified for drugs (as no drugs interact with this lncRNA)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIVEP2 divergent transcript (HIVEP2-DT).